The timing could hardly be more awkward. TKMS executives are preparing to pitch institutional investors in London on the same day the stock trades roughly 11 percent below the record high it set just days ago. The shares, changing hands at €96.50, have surrendered ground since touching €108.80 — yet they still sit 70 percent above their 12-month trough.
That gap between the recent pullback and the longer-term surge is precisely what makes Wednesday’s roadshow so consequential. Management must convince investors that a backlog now stretching to €20.1 billion justifies valuations that some traders already consider stretched.
A consensus forms on the buy side
The consolidation in the share price stands in sharp contrast to what’s happening in analyst offices. Bernstein Research has been the most aggressive, lifting its price target from €76 to €125 and upgrading the stock from “Market-Perform” to “Outperform.” Analyst Adrien Rabier cites sharply rising estimates for the naval shipbuilder, including an 86 percent increase in the firm’s 2030 EBIT forecast.
Others are following, if less dramatically. Metzler has added €10 to its target, now at €115, keeping its buy recommendation intact. Deutsche Bank has nudged its objective from €110 to €112 while reaffirming a Buy rating. The common thread: fresh large-scale orders and a profitability trajectory that appears to be inflecting upward.
The €100 debate splits the retail crowd
Among private investors, the question isn’t whether TKMS is a good company — it’s whether the stock can hold above the psychologically important €100 mark.
One camp sees further downside. They’re anticipating a broader market consolidation that could drag the shares below €90, and several traders report taking profits in the €95-to-€100 zone, with re-entry plans penciled in around €85. The other faction views the recent weakness as a healthy pause after a steep ascent, pointing to the fundamentals as evidence the rally has further to run.
The numbers behind the optimism
The company’s own disclosures support the bullish case. TKMS has raised its revenue guidance for fiscal 2025/26 for the second time in six months, now targeting growth of 10 to 12 percent — a substantial upgrade from the 2 to 5 percent range initially communicated. The EBIT margin outlook has also improved, moving from “more than 6 percent” to “up to 6.5 percent.”
Should investors sell immediately? Or is it worth buying TKMS?
The nine-month figures provide the backdrop. Revenue reached €1.890 billion, with adjusted EBIT of €110 million. Order intake during the period hit €3.617 billion, and the backlog — the metric that matters most for a shipbuilder — stood at €20.1 billion. That level of visibility is rare in an industry where order books can stretch a decade or more.
The submarine division deserves particular attention. Segment revenue jumped 72 percent, with a stable EBIT margin of 6.5 percent — a combination analysts read as evidence that the unit’s expansion isn’t coming at the expense of profitability.
What’s already in the pipeline — and what isn’t
The headline orders are well known: four MEKO A-200 DEU frigates with an option for four more, two additional 212CD submarines for the Norwegian government, and a framework agreement for heavyweight torpedoes under the same program. Crucially, these contracts were signed after the quarter closed, meaning they’ll feed future revenue rather than the reported nine-month figures.
Reuters has also flagged demand from the Middle East following the Iran conflict, particularly for TKMS’s mine-countermeasure technology. The CEO has characterized this as an additional growth driver — one that wasn’t captured in the existing forecasts.
For investors, that raises an intriguing possibility: the current guidance may already be outdated. The combination of a second guidance hike, fresh contract wins, and a new demand source from a region that wasn’t part of the original planning assumptions suggests the operational momentum is accelerating rather than plateauing.
The question London investors will ask
The stock has climbed 22 percent over the past 30 days, a move that tracks almost perfectly with the guidance upgrade and the new order announcements. The fundamental case — improved earnings quality, a swelling backlog, and margin expansion — is well documented.
What remains unresolved is whether the market’s expectations have now run ahead of what management can deliver. The London roadshow gives TKMS the platform to address that directly. How the executive team frames the record order book against already-elevated investor expectations will likely determine whether the next leg of this trade is driven by fundamentals or by the simple math of supply and demand for a stock that’s suddenly in vogue.
Ad
TKMS Stock: Buy or Sell?! New TKMS Analysis from August 19 delivers the answer:
The latest TKMS figures speak for themselves: Urgent action needed for TKMS investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 19.
TKMS: Buy or sell? Read more here...
